Literature DB >> 30320089

Early and Late Histological and Ultrastructural Findings in Resected Infantile Capillary Hemangiomas Following Treatment with Topical Beta-Blocker Timolol Maleate 0.5.

Zuzana Sipkova1, Kanmin Xue1,2, Hardeep S Mudhar3, Bart Wagner4, Göran Darius Hildebrand1,5.   

Abstract

BACKGROUND: Infantile capillary hemangiomas (IHs) affect approximately 4-5% of infants. The systemic nonselective β-adrenergic antagonist, propranolol, has become the standard first-line treatment for severe IHs. The topical β-antagonist, timolol maleate, has also demonstrated efficacy and safety in treating superficial and some deep capillary hemangiomas. Despite their therapeutic success and prevalent use, the mechanism of action of β-adrenergic antagonists in the treatment of IHs is not well understood.
METHODS: Histopathological and electron microscopic evaluation of two periocular IHs excised at 1 week and 24 months following topical timolol treatment was performed.
RESULTS: Distinct morphological differences were observed between spontaneously regressed and β-antagonist-treated IHs. The former was characterized by diffuse collagen deposition and interstitial fibrosis, while the latter showed organized concentric collagen IV deposition within obliterated vessel lumen, suggestive of waves of endothelial cell apoptosis, leaving behind layers of basement membrane deposits as a stress response.
CONCLUSIONS: Based on these observations, we hypothesize that, apart from their well-known cardiac and vasodilatory effects, β-antagonists could induce endothelial cell apoptosis in IH leading to endovascular occlusion and we present supporting evidence to explain why this response might be specific to hypoxic tissue.

Entities:  

Keywords:  Infantile capillary hemangioma; Topical timolol maleate 0.5%; Topical β-blocker

Year:  2017        PMID: 30320089      PMCID: PMC6167667          DOI: 10.1159/000477411

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  14 in total

Review 1.  Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.

Authors:  C H Storch; P H Hoeger
Journal:  Br J Dermatol       Date:  2010-05-08       Impact factor: 9.302

2.  Increased apoptosis and secretion of tryptase by mast cells in infantile haemangioma treated with propranolol.

Authors:  Ryan Steel; Darren Day
Journal:  Pathology       Date:  2014-10       Impact factor: 5.306

3.  Deep periocular infantile capillary hemangiomas responding to topical application of timolol maleate, 0.5%, drops.

Authors:  Kanmin Xue; Göran Darius Hildebrand
Journal:  JAMA Ophthalmol       Date:  2013-09       Impact factor: 7.389

4.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

5.  Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution.

Authors:  Suqin Guo; Nina Ni
Journal:  Arch Ophthalmol       Date:  2010-02

6.  Regulation of glucose transporter protein-1 and vascular endothelial growth factor by hypoxia inducible factor 1α under hypoxic conditions in Hep-2 human cells.

Authors:  Ou Xu; Xiaoming Li; Yongtao Qu; Shuang Liu; Jie An; Maoxin Wang; Qingjia Sun; Wen Zhang; Xiuying Lu; Lihong Pi; Min Zhang; Yupeng Shen
Journal:  Mol Med Rep       Date:  2012-09-11       Impact factor: 2.952

Review 7.  Infantile hemangiomas, retinopathy of prematurity and cancer: a common pathogenetic role of the β-adrenergic system.

Authors:  Luca Filippi; Massimo Dal Monte; Giovanni Casini; Marta Daniotti; Federica Sereni; Paola Bagnoli
Journal:  Med Res Rev       Date:  2014-12-19       Impact factor: 12.944

Review 8.  Review of topical beta blockers as treatment for infantile hemangiomas.

Authors:  Sally L Painter; Göran Darius Hildebrand
Journal:  Surv Ophthalmol       Date:  2015-09-25       Impact factor: 6.048

9.  Propranolol induces regression of hemangioma cells through HIF-1α-mediated inhibition of VEGF-A.

Authors:  Harvey Chim; Bryan S Armijo; Erin Miller; Christy Gliniak; Marc A Serret; Arun K Gosain
Journal:  Ann Surg       Date:  2012-07       Impact factor: 12.969

10.  Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis.

Authors:  Jessica Stiles; Clarissa Amaya; Robert Pham; Rebecca K Rowntree; Mary Lacaze; Arlynn Mulne; Joyce Bischoff; Victor Kokta; Laura E Boucheron; Dianne C Mitchell; Brad A Bryan
Journal:  Exp Ther Med       Date:  2012-08-03       Impact factor: 2.447

View more
  2 in total

1.  Role of topical beta blockers in regression of infantile capillary hemangioma.

Authors:  Murtaza Sameen Junejo; Maria Nazish Memon; Sajida Parveen Shaikh
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

2.  Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers.

Authors:  Aoife Naughton; Ariel Yuhan Ong; Goran Darius Hildebrand
Journal:  Pediatr Rep       Date:  2021-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.